We report here that, contrary to previously reported findings, treatment of S49 wild-type (WT) lymphoma cells with 0-50 nM epinephrine resulted in a heterologous desensitization of adenylyl cyclase (EC 4.6.1.1)-that is, epinephrine and prostaglandin El (PGEI) stimulations of adenylyl cyclase were reduced. Observation of this heterologous desensitization required the assay of adenylyl cyclase with submillimolar concentrations of Mg2+ and low concentrations of epinephrine. Also, whereas previously there had been no evidence for any role of cAMP-dependent protein kinase in the desensitization of the WT fi-adrenergic receptor, our data comparing the characteristics of the desensitization in WT, kin-, and cyc -lymphoma cells [where kin -and cyc -refer to variants of S49 WT cells lacking cAMP-dependent protein kinase activity (kin-) and the a subunit of the stimulatory guanine nucleotide-binding regulatory protein (cyc -)] now suggest that cAMP-dependent protein kinase mediates the heterologous desensitization of adenylyl cyclase. Specifically, we found that only the WT cells exhibited epinephrine-induced heterologous desensitization. The kin -and cyc-cells exhibited only homologous desensitization, and much higher concentrations of epinephrine were required to elicit the homologous desensitization in the variants relative to the heterologous desensitization of the WT. Treatment of WT and cyc-cells with dibutyryl cAMP or treatment of WT with forskolin or PGE, caused the heterologous desensitization of adenylyl cyclase, indicating that neither receptor occupancy nor activation of adenylyl cyclase was necessary for the heterologous desensitization'.
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For some time now it has been widely thought that epinephrine-induced desensitization of the B-adrenergic receptor in wild-type (WT) S49 lymphoma cells was homologous and that it did not require the a subunit of the stimulatory guanine nucleotide-binding regulatory protein (Gsa), cAMP, or cAMP-dependent protein kinase (1) (2) (3) (4) (5) (6) (7) (8) (9) . Support for this was derived in large part from studies of the various mutants of the WT defective in components of the cAMP second messenger system. In particular, we demonstrated that homologous, agonist-induced desensitizations of either the pS-adrenergic or the prostaglandin E1 (PGE,)-responsive adenylyl cyclase (EC 4.6.1.1) required rather high levels of receptor occupancy and were indistinguishable in the WT and cyc -mutant (the cyc -S49 mutant lacks Gsa) (4) (5) (6) (7) .
Recently we presented data that, in contrast to earlier studies, revealed a major difference in epinephrine-induced desensitization between WT and cyc -cells and raised once again the possibility that either cAMP, cAMP-dependent protein kinase, or Gsa was involved in the desensitization of S49 lymphoma cells (10) . We found that incubation of WT cells with 5-50 nM epinephrine desensitized epinephrine stimulation of the WT adenylyl cyclase but that even 50 nM epinephrine had no effect on the response of cyc -cells.
Observation of this difference in the desensitization of adenylyl cyclase between the WT and cyc -cells was dependent on the use, in our adenylyl cyclase assays, of submillimolar concentrations of Mg2", which appear to reflect the intracellular concentration of free Mg2+ in these cells (11, 12) .
The original intent of the present experiments was to clarify the role of cAMP and Gsa in the homologous desensitization of the f3-adrenergic receptor in response to the treatment of WT cells with low concentrations of epinephrine. In the process we discovered, to our surprise, that the desensitization of WT cells in response to low concentrations of epinephrine was heterologous, not homologous, and that it required increased levels of cAMP and activation of cAMP-dependent protein kinase. This has led us to propose a model in which the desensitization of the WT ,B-adrenergic receptor is mediated by two separate pathways. One, which is triggered by low concentrations of hormones or other agents that raise cAMP levels, appears to be mediated by cAMP-dependent protein kinase and leads to heterologous desensitization. The other pathway, which requires much higher levels of epinephrine, appears to be independent of cAMP and leads to homologous desensitization. ascorbate/thiourea alone. For experiments involving pretreatment of cyc-cells with dibutyryl cAMP, the time of incubation was 20 min with dibutyryl cAMP; this was followed by a 10-min incubation with ascorbate/thiourea or epinephrine in ascorbate/thiourea. For treatments with forskolin and PGE1, stock solutions were made in ethanol and diluted into the cell mixture such that the final concentration of ethanol was <0.1%.
METHODS
Following the pretreatments, the cells were rapidly cooled in an ice bath, collected by centrifugation, washed one time in ice-cold buffer A (137 mM NaCl/5.36 mM KCI/1.1 mM KH2PO4/1.08 mM Na2HPO4, pH 7.2), and resuspended in ice-cold buffer B (150 mM NaCl/20 mM Hepes/1 mM EDTA, pH 7.4) containing 5 mM NaH2PO4 and 10 mM NaF as phosphatase inhibitors and 1.0 mM benzamidine as a protease inhibitor.
Following resuspension in buffer B, cells were lysed by nitrogen cavitation in a Parr cell disruption bomb on ice at 500 psi (1 psi = 6.89 kPa) of nitrogen for 20 min. The cell lysate was collected and centrifuged at 600 x g to remove nuclei and cell debris. Alternatively, for most of the WT and kin -experiments shown in Fig. 3 , the cells were lysed by 20 strokes of a Dounce homogenizer in a buffer composed of 20 mM Hepes, 1 mM EDTA, 1 mM benzamidine, 10 ;Lg of leupeptin per ml, 5 mM NaH2PO4, and 10 mM tetrasodium pyrophosphate (pH 7.2). This allowed processing of a greater number of samples. Similar results were obtained for the % desensitization of adenylyl cyclase with the two methods of cell breakage, although we consistently found a higher Kact for epinephrine stimulation of adenylyl cyclase with the homogenization technique.
The 600 x g supernatant fraction resulting from either method of lysis was layered over a step gradient containing 43%, 35%, 31%, 27%, 23%, and 19%o sucrose in 20 mM Hepes/1 mM EDTA, pH 8. The gradients were centrifuged for 80 min at 25,000 rpm in a Beckman SW27 rotor, and the membrane fractions were removed and immediately frozen.
Reconstitution of cyc-Adenylyl Cyclase. Adenylyl cyclase activity in cyc-membranes was reconstituted by the procedure of Sternweis and Gilman (15), modified as described (10 (13, 18) .
RESULTS
Epinephrine Treatment of WT Cells Leads to Heterologous Desensitization of Adenylyl Cyclase. We had previously demonstrated that the desensitization of WT and cyc -adenylyl cyclase by either epinephrine or PGE1 was homologous. This was based for the most part on experiments involving treatment of cells with relatively high concentrations of hormones and on cell-free assays of adenylyl cyclase in the presence of high Mg2 + concentrations (4-7). We have recently shown that increasing Mg2+ in the range of 0.1-10 mM progressively obscures epinephrine-induced desensitization of the WT adenylyl cyclase (10) . Use of the low Mg2+ concentrations in our adenylyl cyclase assays enabled us to observe desensitization of epinephrine-stimulated adenylyl cyclase following treatment of cells with 5-20 nM epinephrine (10), concentrations that had previously been shown to cause desensitization in intact WT cells (19, 20) .
Originally we presumed that the low Mg2+ assay conditions affected only our observation of the extent of desensitization of epinephrine stimulation; however, many experiments such as that shown in Fig. 1 demonstrated that PGE1 stimulation of adenylyl cyclase was desensitized as well. In this experiment WT cells were pretreated with various low concentrations of epinephrine. Membranes prepared from control and pretreated cells were assayed for adenylyl cyclase in the presence of either epinephrine (50 nM or 10 MM) or 200 nM PGE1. The free Mg2+ concentration in the assay was 0.3 mM. The extent of desensitization of adenylyl cyclase stimulated by either 50 nM epinephrine or 200 nM PGE1 was similar following treatment with 5 or 10 nM epinephrine. Thus, the desensitization induced by low concentrations of epinephrine was heterologous, not homologous. When cells were desensitized with 50 nM epinephrine the loss of epinephrine stimulation of adenylyl cyclase was somewhat greater relative to the loss of PGE1 stimulation. Further increase of the concentration of epinephrine led to additional desensitization of the epinephrine stimulation of adenylyl cyclase but not of the PGE1 stimulation. Pretreatment of WT cells with 1.0 MM epinephrine for 15 min led to an 87.5% ± 4.8% desensitization of 50 nM epinephrine stimulation of adenylyl cyclase and only a 34% ± 10% desensitization of 5.0 MM PGE1 stimulation (mean ± range, n = 2). These differences between the extent of epinephrine and PGE1 desensitization were observed consistently following pretreatment with 250 nM epinephrine and reflect the increasing contribution of homologous desensitization that appears to be half-maximal in WT cells at an epinephrine concentration of about 200 nM (5, 7).
The experiment in Fig. 1 Fig. 2 . cyc -cells were incubated for 30 min at 37°C with either no additions (0.1 mM ascorbate/1 mM thiourea), 50 ,uM dibutyryl cAMP, 50 nM epinephrine in ascorbate/thiourea, or dibutyryl cAMP in combination with epinephrine. Epinephrine was present for the last 10 min of the 30-min incubation. Following the intact cell treatment, membranes were prepared, reconstituted with cholate extracts of WT membranes, and assayed for adenylyl cyclase activity with either 30 nM, 60 nM, or 10 ,uM epinephrine. As previously reported (10), the pretreatment with 50 nM epinephrine alone caused no desensitization, whereas treatment with dibutyryl cAMP with or without epinephrine caused about a 35-45% desensitization of the 30 and 60 nM epinephrine stimulations but had almost no effect on stimulation (59%o + 3%, n = 3, and 27% + 5%, n = 4, respectively); thus, the desensitization was heterologous. A similar pattern of heterologous desensitization was caused by dibutyryl cAMP treatment of UNC cells. Since these cells lack hormonal stimulation of adenylyl cyclase due to a defective Gsa, membranes were reconstituted prior to adenylyl cyclase assays by the same procedure used for the cyc membrane preparations. We have also shown that 50 ,uM butyrate caused no desensitization of adenylyl cyclase following treatment of either the cyc-or the WT cells.
Epinephrine Pretreatment Does Not Induce Heterologous Desensitization in kin-Cells. The dibutyryl cAMP-and forskolin-induced heterologous desensitization in the WT and cyc -cells suggested that activation of cAMP-dependent protein kinase was essential for the heterologous desensitization of adenylyl cyclase. A variant of the S49 WT lymphoma cell designated kin-, which lacks detectable cAMPdependent protein kinase activity, provided us with a means of directly testing the role of cAMP-dependent protein kinase in heterologous desensitization. It had been shown previously that kin -cells undergo homologous desensitization in response to relatively high concentrations of catecholamines (8, 21) .
Our first approach was to compare the extent of desensitization of adenylyl cyclase in WT and kin -cells following pretreatment with from 5-50 nM epinephrine. The data shown in Fig. 3 , the compilation of >15 experiments, demonstrated that about 4-fold higher concentrations of epinephrine were required to observe desensitization in the kin -cells. Pretreatment of WT cells with 5 and 10 nM epinephrine resulted in 22% and 28% desensitization of 50 nM epinephrine stimulation of adenylyl cyclase, and yet these same concentrations of epinephrine did not desensitize the kin-cells. These results were confirmed by intact cell studies in which the accumulations of cAMP in WT and kincells were measured following stimulation with 10 nM epinephrine. We found that 10 nM epinephrine rapidly desensitized the WT cells-that is, it caused the expected rapid rise and fall in cAMP consistent with earlier work (data not shown). In contrast, the extent of desensitization was much less in the kin -cells. Even though the initial rates of cAMP synthesis in the two lines were similar, as indicated by cAMP accumulations after 2 min, the kin-cells were able to maintain much higher cAMP levels after 10 min. In fact, accumulation of cAMP in the kin-cells was 12-to 15-fold higher than in the WT cells at 20 min. Since the desensitization in response to the incubation of WT cells with low epinephrine concentrations was heterologous (see Fig. 1 ), the kin -results suggested that there may be no heterologous desensitization of adenylyl cyclase in the kin -cell line in response to treatment with the very low concentrations of epinephrine.
The lack of heterologous desensitization of the kin -cells was confirmed by experiments such as that shown in Fig. 4 in which kin -cells were pretreated with 80 nM epinephrine for 15 min. This treatment caused about a 50% desensitization of 50 nM epinephrine stimulation of adenylyl cyclase but no significant desensitization of the PGE1 stimulation, thus demonstrating that the desensitization of the kin -adenylyl cyclase was purely homologous. Higher epinephrine concentrations, though increasing the extent of the homologous desensitization (e.g., 1.0 AM epinephrine induced an 85% desensitization of epinephrine stimulation of adenylyl cyclase), still did not result in any heterologous desensitization of PGE1 stimulation. Similar results have been obtained with another kin -clone, U200/19, that was isolated from the WT cells independently and also lacks measurable cAMP-dependent protein kinase. These results suggested that cAMP-dependent protein kinase mediates the heterologous desensitization of adenylyl cyclase.
DISCUSSION
Recently Lefkowitz's group reported the isolation of an apparently unique protein kinase (f8-adrenergic receptor kinase) from kin -cells whose capacity to phosphorylate the purified lung f3-adrenergic receptor in liposomes was dependent on agonist occupancy of the receptor but apparently independent of cAMP, Ca2 +, or calmodulin (22) . The dependency of its in vitro action on a high level of receptor occupancy suggested that it was a possible candidate for the mediator of homologous desensitization of WT cells, and this group proposed that /-adrenergic receptor kinase mediated the desensitization of the 83-adrenergic receptor in mammalian cells. At the time this hypothesis was proposed, homologous desensitization was the only type of desensitization thought to occur in response to f3-adrenergic agonist treatment of the S49 WT cells. The requirement for a high level of receptor occupancy made it unlikely that fadrenergic receptor kinase was involved in the more physi- (1988) ologic desensitization induced by low concentrations of hormones (10, 19, 20) .
The data we have reported here have led us to modify previous hypotheses concerning the mechanisms of desensitization of the S49 WT lymphoma cells and to suggest that the rapid, agonist-induced desensitization of hormonal stimulation of adenylyl cyclase in WT cells involves two separate pathways, as shown in Fig. 5 . The heterologous pathway requires cAMP and cAMP-dependent protein kinase and is active when WT cells are pretreated with low concentration of either epinephrine, PGE1, or forskolin. It remains to be determined whether there are other steps in a cascade analogous to cAMP-dependent protein kinase, regulation of phosphorylase by means of phosphorylase kinase, orinactivation of a phosphatase by means of activation of an inhibitor. The second pathway, which leads to homologous desensitization, is independent of either cAMP or cAMPdependent protein kinase and requires much higher levels of hormones. Homologous desensitization may be synonymous with sequestration-internalization, since they appear to occur over a similar range [effective concentration for halfmaximal desensitization (EC50) 200 nM] of epinephrine concentrations in the WT (5, 7). The requirement for high ligand occupancy of the j8-adrenergic receptor engenders speculation that this process may be triggered by f3-adrenergic receptor kinase as previously suggested (22) . In our model we suggest that the phosphorylation by f3-adrenergic receptor kinase involves sites different from those for cAMP-dependent protein kinase and does not desensitize the ,3-adrenergic receptor but rather is the signal that leads to sequestration-internalization. Physical isolation of the receptor then prevents receptor-adenylyl cyclase coupling.
One of the questions that surfaces based on our results is how general the role of cAMP-dependent protein kinase will be in heterologous desensitization of adenylyl cyclase. There Model for the desensitization of adenylyl cyclase in S49 WT lymphoma cells. In this model the following abbreviations were used: R and R* inactive and hormone-activated states of the stimulatory receptor; R'-P, desensitized state of the receptor following phosphorylation by cAMP-dependent protein kinase; R"-P, still active state of the receptor following phosphorylation by /3-adrenergic receptor kinase (BARK) at a site or sites distinct from those phosphorylated by cAMP-dependent protein kinase; H, stimulatory hormone; RLV, internalized receptor in light vesicle; p'tase, phosphatase; cA-PK, cAMP-dependent protein kinase. Epinephrine concentrations in parentheses are those that provoke rapid heterologous (0-20 nM) or homologous and heterologous (20-1000 nM) desensitization in S49 WT cells.
has been ample evidence (1) (2) (3) that cAMP causes desensitization of the /3-adrenergic receptor in other systems, most notably the turkey erythrocyte (3), the C6-2B glioma cell line (23) , and the astrocytoma cell line (24) . In cultured mammalian cells there has been a real problem with the detection of heterologous desensitization of adenylyl cyclase in cell-free preparations. There is a distinct possibility that the heterologous desensitization in the mammalian cells may have been obscured in previous work by the use of only high concentrations of hormones in the pretreatment and the assay of epinephrine stimulation of adenylyl cyclase, as well as in the use of high Mg2+ concentrations in the adenylyl cyclase assays, which we have recently shown obscures heterologous desensitization (10) .
We gratefully acknowledge continued support from Grant AU-878 from the Robert A. Welch Foundation. We also appreciate the assistance of Ms. Genevie Ponce in the preparation of this manuscript.
